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Abstract
Characterization of the genetic defects causing gonadotropic deficiency has made a major contribution to elucidation of the
fundamental role of Kisspeptins and Neurokinin B in puberty onset and reproduction. The absence of puberty may also
reveal neurodevelopmental disorders caused by molecular defects in various cellular pathways. Investigations of these
neurodevelopmental disorders may provide information about the neuronal processes controlling puberty onset and
reproductive capacity. We describe here a new syndrome observed in three brothers, which involves gonadotropic axis
deficiency, central hypothyroidism, peripheral demyelinating sensorimotor polyneuropathy, mental retardation, and
profound hypoglycemia, progressing to nonautoimmune insulin-dependent diabetes mellitus. High-throughput
sequencing revealed a homozygous in-frame deletion of 15 nucleotides in DMXL2 in all three affected patients. This
homozygous deletion was associated with lower DMXL2 mRNA levels in the blood lymphocytes of the patients. DMXL2
encodes the synaptic protein rabconnectin-3a, which has been identified as a putative scaffold protein for Rab3-GAP and
Rab3-GEP, two regulators of the GTPase Rab3a. We found that rabconnectin-3a was expressed in exocytosis vesicles in
gonadotropin-releasing hormone (GnRH) axonal extremities in the median eminence of the hypothalamus. It was also
specifically expressed in cells expressing luteinizing hormone (LH) and follicle-stimulating hormone (FSH) within the
pituitary. The conditional heterozygous deletion of Dmxl2 from mouse neurons delayed puberty and resulted in very low
fertility. This reproductive phenotype was associated with a lower number of GnRH neurons in the hypothalamus of adult
mice. Finally, Dmxl2 knockdown in an insulin-secreting cell line showed that rabconnectin-3a controlled the constitutive
and glucose-induced secretion of insulin. In conclusion, this study shows that low levels of DMXL2 expression cause a
complex neurological phenotype, with abnormal glucose metabolism and gonadotropic axis deficiency due to a loss of
GnRH neurons. Our findings identify rabconectin-3a as a key controller of neuronal and endocrine homeostatic processes.
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Introduction
Puberty is defined by the appearance of secondary sexual
characteristics and the maturation of reproductive function. It is
driven by an increase in sexual steroid hormone synthesis by the
gonads, under the control of the hypothalamo–pituitary hormonal
axis [1]. The key event in puberty initiation is an increase in the
pulsatile release of GnRH by hypothalamic neurons, triggering the
release of luteinizing hormone (LH) and follicle-stimulating
hormone (FSH) by the pituitary gland [2]. This pubertal increase
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in GnRH secretion is associated with increases in glutamatergic
inputs and decreases in GABAergic inputs to GnRH neurons [3].
It is also facilitated by hypothalamic glial cells, which interact
directly or indirectly with GnRH neurons [4]. Kisspeptins (KPs)
are currently thought to be the principal hypothalamic neuropep-
tides controlling GnRH secretion in mammals, not only at puberty
but also during adulthood [5,6]. The activation of the KP signaling
pathway in the hypothalamus is seen as the major hallmark of
puberty onset [5,6], and its control is partly epigenetic [7].
Congenital hypogonadotropic hypogonadism (CHH) is a
medical condition defined by a defect of the hypothalamo–
pituitary–gonadotropic (HPG) axis resulting in an absence of
puberty and infertility in adulthood. Characterization of the
genetic defects underlying the isolated form of CHH [8–12] has
proved crucial, not only for elucidating the fundamental role of
KPs in the central regulation of the gonadotropic axis and puberty
[5,6] but also for determining the role played by Neurokinin B
(NKB) [13]. CHH may be associated with anosmia, due to
olfactory bulb agenesis, in Kallmann syndrome (KS) [14,15]. In
KS, GnRH neurons fail to leave the olfactory placode (OP).
Indeed, GnRH neurons, unlike other neurons of the CNS, migrate
early in embryogenesis, from the OP into the hypothalamus, along
the olfactory tract [16]. All genes linked to KS encode proteins
necessary for olfactory bulb development or for the migration and
maturation of GnRH neurons [15].
CHH has also been described in highly complex neurodevel-
opmental disorders caused by loss-of-function mutations in genes
encoding proteins involved in diverse cellular pathways [17–21].
This association indicates that the same etiopathogenic mecha-
nism may be responsible for a specific neuroendocrine deficiency
and common neurological dysfunctions. We recently decided to
investigate these common mechanisms further, by characterizing
the molecular mechanism of a new syndrome that associates
GnRH deficiency with complex neurological and endocrine
phenotypes. A genetic analysis of this family revealed that this
phenotype was due to a weak expression of DMXL2, encoding
Rabconnectin-3a. Through in vivo and in vitro analysis of
rabconnectin-3a expression and function, we discovered that weak
Dmxl2 expression in the adult mouse brain resulted in a loss of
GnRH neurons in the hypothalamus. These findings established a
novel molecular mechanism leading to gonadotropic axis defi-
ciency and paved the way for improvements in our understanding
of the neuroendocrine control of reproduction.
Results
Phenotype
We investigated a consanguineous Senegalese family with five
children, three of whom had an unusual, progressive endocrine
and neurodevelopmental disorder, with similar clinical features in
each case (Figure 1A and Table 1). This syndrome began early in
childhood, with growth retardation and recurrent episodes of
profound asymptomatic hypoglycemia (blood glucose concentra-
tion as low as 1.6 mmol/l), with an incomplete suppression of
insulin concentrations (2 to 4 mIU/l), appearing between the ages
of 2 and 5 ys. Between the ages of 14 and 16 y, the three brothers
gradually developed progressive nonautoimmune insulin-depen-
dent diabetes mellitus. Their puberty was incomplete and they had
a low testicular volume. All the brothers had a normal sense of
smell. During adolescence, the brothers had walking difficulties,
such as ataxia and dysarthria. Neurological examination showed
polyneuropathy, with a motor deficit predominantly affecting the
proximal lower limbs, pes cavus, and claw toes, together with
cerebellar and pyramidal signs. Electrophysiological patterns were
consistent with a demyelinating polyneuropathy, with a diffuse
homogeneous pattern of slowing motor conduction in peripheral
nerves (23–42 m/s; N.50 m/s) and greater preservation of
sensory conduction in the legs than in the arms. Brain MRI
showed moderate subcortical temporal white matter disease, and
one patient (no. 123) also had mild hypoplasia of the cerebellum
and a small anterior pituitary. The posterior lobe of the pituitary
was in the correct position.
Hormonal assays in adulthood showed an increase in HbA1c
levels to up to 11.7%, with low insulin concentrations in an
intravenous glucose tolerance test and subnormal basal C-peptide
secretion; serum-free T4 concentrations were low, with normal
TSH concentrations (Table 2). The effects of TRH administration
indicated that this central hypothyroidism was probably of
hypothalamic origin. All three brothers had low plasma testoster-
one concentrations for their age, along with low LH and FSH
concentrations. A GnRH test (100 mg i.v.) was performed in two
patients (nos. 123 and 124 at 21 and 20 y of age, respectively). It
revealed a large increase in LH concentrations associated with a
normal increase in FSH concentrations (Table 2).
The mother experienced menarche at the age of 13 y and her
first spontaneous pregnancy occurred at 20 y. The father reported
normal pubertal development. He developed glucose intolerance
by the age of 46 y. Both parents were of normal height, at 160 and
175 cm.
Characterization of the DMXL2 Mutation
Assuming a fully penetrant recessive transmission model with a
disease allele frequency of 0.00001, two candidate regions were
identified on chromosomes 13 and 15, with a LOD score of 2.5
(Figure 1B). These two regions harbored 164 and 341 genes.
High-throughput sequencing of all exons of both candidate regions
in the DNA of the proband and his mother revealed an in-frame
deletion of 15 nucleotides (c.5824_5838del) in exon 24 of DMXL2,
which encodes rabconnectin-3a (Rbcn-3a) (Figure 1C and Figure
S1). This deletion results in the deletion of five amino-acid residues
SDGNG (p.1942_1946del) (Figure 1C). Both parents and one
unaffected sister were heterozygous for the deletion; one unaffect-
ed sister did not carry the deletion (Figure S1). This pattern of
Author Summary
Investigation of neurodevelopmental disorders with ab-
normal puberty can reveal neuronal processes that control
the initiation of puberty and subsequent reproductive
function. We describe here a new syndrome observed in
three brothers with incomplete puberty, central hypothy-
roidism, peripheral polyneuropathy, mental retardation,
and abnormal glucose regulation. Molecular genetic
investigation in this consanguineous family revealed an
in-frame deletion of 15 nucleotides in the DMXL2 gene,
which resulted in lower levels of its expression. We found
that rabconnectin-3a, the synaptic protein encoded by
DMXL2, is widely expressed in the brain and in the ends of
the axons of neurons that produce gonadotropin-releasing
hormone (GnRH). We then observed that neuron-specific
deletion of one allele of Dmxl2 in mice reproduces the
incomplete puberty seen in the human patients and
results in decreased numbers of GnRH neurons in the
hypothalamus. We also showed that rabconnectin-3a
controls glucose-induced insulin secretion. These findings
reveal a new mechanism of gonadotropin deficiency and
identify rabconnectin-3a as a key controller of neuronal
and endocrine homeostasis.
Rabconnectin-3a in the Control of Puberty Onset
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familial segregation is consistent with recessive transmission. The
Ser1942 residue is highly conserved between species, whereas the
other four residues are not well conserved. We suspected that the
15-nucleotide deletion in DMXL2 might modify the level of
expression of this gene [22]. In fact, quantitative RT-PCR showed
that there was significantly less DMXL2 mRNA in homozygous
c.5824_5838del patients than in heterozygous or wild-type (WT)
family members and unrelated controls (Figure 1D). These results
suggested that the c.5824_5838del probably exerted its pathogenic
effects by decreasing the expression of DMXL2. We tested this
hypothesis by searching for DMXL2 mutations in 10 cases of HH
with a similar phenotype. No DMXL2 mutation was found in any
of these patients. We therefore carried out studies in rodents, to
confirm the link between the decrease in DMXL2 expression and
the phenotype.
Expression of Dmxl2 and Rbcn-3a in Rodent Brain and
Pituitary
Rbcn-3a is a synaptic protein that interacts closely with WDR7
[23] and may serve as a scaffold protein for both Rab3-GEP and
Rab3-GAP on synaptic vesicles [23,24]. Rbcn-3a has also been
implicated in the regulation of Notch signaling, through the
modulation of v-ATPAse activity in mammalian and insect cells
[25]. We therefore analyzed the expression of Dmxl2 and Rbcn-3a
in both the brain and pituitary in rodents. Both Dmxl2 mRNA and
Rbcn-3a were detected in the hippocampus, dentate gyrus,
Figure 1. DMXL2 is mutated in affected patients. (A) Pedigree of the affected family. Closed symbols indicate affected individuals. (B) Linkage
analysis delineated two candidate regions on chromosomes 13 and 15 with a LOD score of 2.5. (C) Next-generation sequencing characterized a
deletion of 15 nucleotides (c.5824_5838del) in exon 24 of DMXL2. This deletion removes five amino acids (p.1942_1946del). Rbcn-3a is a protein with
17 WD domains (green box) and one Rav1p_C domain, which is involved in regulating the glucose-dependent assembly and disassembly of the V1
and V0 subunits of the vacuolar ATPase (purple box) [57]. (D) Quantification, by RT-qPCR, of DMXL2 mRNA levels relative to RNA 18S levels in blood
lymphocytes. Error bars, SEM. * p,0.05. Numerical data used to generate graph 1D may be found in Table S5.
doi:10.1371/journal.pbio.1001952.g001
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hypothalamus, pyriform cortex (Figure 2A–E), and the granular
and molecular layers of the cerebellum of adult mice (Figure S2).
In the hypothalamus, immunostaining for Rbcn-3a was observed
in the arcuate nucleus (ARC), the median eminence (ME),
the organum vasculosum of the lamina terminalis (OVLT),
(Figure 2C,D), and the subfornical organ (SFO), the subcommissural
Table 1. Summary of the clinical phenotype of the three affected patients with DMXL2 mutations (see Figure 1 for patient
numbering).
Patient #123 #124 #125
Age (years) 21.4 20.3 16.8
Weight at birth g (SDS) 2,700 (22.2) 2,810 (20.9) 3,060 (21.1)
Height at birth cm (SDS) 46 (22.5) 47 (21.1) 49 (20.8)
Postnatal growth retardation + + +
Height cm (SDS) 159 (22.8) 165 (21.8) 156 (22.5)
Body mass index kg/m2 (SDS) 17.4 (21.9) 21.3 (20.2) 15.2 (22.0)
Head circumference, cm (SDS) 54.5 (21.9) 56 (20.8) 51.5 (22.5)
Ataxia + + +
Dystonia + + +
Demyelinating sensorimotor polyneuropathy + + +
Pyramidal syndrome + + +
Motor delay + + +
Dysarthria + + +
Partial frontal alopecia + + +
Intellectual disability (moderate) + + +
White matter disease (moderate subcortical, temporal) + + +
Hypoglycemia during childhood (asymptomatic) + + +
Nonautoimmune insulin-dependent diabetes mellitus + + +
Hypogonadotropic hypogonadism + + +
Low testicular volume (normal values in young adults .12 ml) 5 ml 7 ml 8 ml
Central hypothyroidism + + +
Hypoplastic pituitary gland + 2 2
Other features Progressive hearing loss
SDS, standard deviation score.
doi:10.1371/journal.pbio.1001952.t001
Table 2. Hormonal status of the three affected patients.
Patient #123 #124 #125
Age (years) 21.4 20 16.8
Plasma testosterone concentration (ng/ml) 1.6 1.9 3.0
FSH (IU/l) basal–peak (after GnRH administration) 6.2–16.2 8.3–28 —
LH (IU/l) basal–peak (after GnRH administration) 6.2–57 4.5–71 —
Inhibin B (pg/ml) 65 87 163
FT4 (pmol/l) 8.5 8.3 8.8
TSH (mIU/l) basal and TRH test 1.7–21.9–7.2 1.5–14–5.6 5.5–29–12.4
Prolactin (ng/ml) 13 12 —
HbA1c % 11 11.7 7.1
Insulinemia (mU/l) (IGTT, T1+T3 min) 11 29 9
C-peptide (nmol/l), fasting concentration 0.31 0.93 0.33
Testosterone, 3–12 ng/ml; GnRH test (100 mg i.v.): normal values for FSH, 1–8.5 IU/l; LH, 1.5–8 IU/l. 60 minutes after GnRH administration, LH and FSH basal
concentrations should have increased by factors of 4.5 and 2, respectively. TRH test (200 mg i.v.): normal values for TSH, 0.5–6, 1467 and ,8 mU/l for basal, peak, and
120-min post-TRH. Inhibin B, normal values in young adults 135–350 pg/ml; Free T4 (FT4), normal values 11–21 pmol/l; Prolactin, normal values ,20 ng/ml; HbA1c,
normal values,5.8%. Insulin concentrations in an intravenous glucose tolerance test (IGTT) at T1+T3 min after glucose administration; normal values .40 mU/l.
C-peptide, normal basal values: 0.3–1.3 nmol/l.
doi:10.1371/journal.pbio.1001952.t002
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organ, and the suprachiasmatic nucleus (SCN) (Figure S2). The
external layer of the ME displayed a punctate pattern of
immunostaining for Rbcn-3a (Figure 2E). Staining was also observed
in the cell bodies lining the third ventricle and in the long processes
extending from these cell bodies toward the external layer of the ME
(Figure 2E). Rbcn-3a was detected in small clear vesicles (Figure 2F)
and in large dense core vesicles (LDCVs) (Figure 2G). This pattern of
staining strongly suggests that both tanycytes and hypothalamic
neurosecretory neurons express Rbcn-3a. In the anterior pituitary of
adult rats, Rbcn-3a immunostaining was observed only in cells
producing LH and FSH (Figure 3A), the pattern observed being
similar to that for Rab3-GEP and Rab3-GAP (Figure 3B). None of
these three proteins colocalized with ACTH, TSH, or GH
(Figure 3C).
In Vivo Investigation of Dmxl2 Deletion in Mice
We then investigated whether a decrease in Dmxl2 expression in
mice could reproduce the phenotype observed in the human
patients. For this purpose, we used a targeted gene-trapping vector
to delete Dmxl2 in mice [26]. In this strategy, the recombinant
allele (tm1a) contained an IRES:LacZ trapping cassette and a
floxed promoter-driven neo cassette in intron 6 and two loxP sites,
one at either end of exon 7 of Dmxl2 (Figure S3). The tm1a allele
encodes a truncated form of Rbcn-3a. Dmxl2-heterozygous
hypomorphic mice (Dmxl2tm1a/wt) displayed no obvious
morphological, growth deficit (Table S1). Dmxl2tm1a/wt mice were
fertile. A tendency for a slightly later vaginal opening (VO), an
important external indicator of puberty onset, and a longer time
between VO and first estrus, were observed in Dmxl2tm1a/wt mice,
but these differences were not significant (Figure S4). Although
fertile, these mice produced no homozygous offspring (Dmxl2tm1a/
tm1a) when crossed (Table S2).
As the gene-trapping method may generate a hypomorphic
allele [27,28] and we expected the severity of the phenotype to be
correlated with Dmxl2 expression levels in neurons, we investi-
gated whether a mouse line with a complete KO of Dmxl2 in
neurons had a more severe phenotype. We crossed Dmxl2tm1a/wt
mice with WT mice expressing the FLIP (flp) recombinase, which
recognizes the FLP recombinase target (FRT) sequence flanking
the b-galactosidase-neomycin cassette in the tm1a allele. This led
to the production of mice bearing two WT alleles, with two loxP
sites flanking exon 7 of Dmxl2 (Dmxl2lox/lox). These Dmxl2lox/lox
mice were then crossed with mice expressing the Cre-recombinase
under the control of the Nestin promoter (nes-Cre;Dmxl2wt/wt)
[29], to obtain mice bearing a Dmxl2 allele from which exon 7 was
deleted in nestin-expressing cells (nes-Cre;Dmxl2–/wt) (Figure S3).
Adult nes-Cre;Dmxl2–/wt mice displayed no obvious morpholog-
ical defects. Hypothalamic Dmxl2 mRNA levels were 50% lower
in nes-Cre;Dmxl2–/wt than in Dmxl2lox/wt mice (Figure S3). Female
nes-Cre;Dmxl2–/wt mice weighed less than WT mice (Figure 4A),
Figure 2. Rbcn-3a is expressed in exocytosis vesicles in the external layer of the median eminence. (A) ISH with a mouse Dmxl2
antisense probe (AS) and a sense probe (S). (B) Immunolabeling with an antibody against Rbcn-3a revealed high levels of Dmxl2/Rbcn-3a expression
in the dentate gyrus, the CA1 and CA3 regions of the hippocampus, and the cortex (black arrowheads). Scale bars, 200 mm. (C and D) Rbcn-3a was
found to be strongly expressed in the external layer of the ME (C) and the OVLT (D). Scale bars, 100 mm. (E) Confocal analysis with an antibody against
Rbcn-3a showed punctate staining in the median eminence and staining of the long processes extending from the cell bodies lining the third
ventricle. (F and G) Rbcn-3a immunoreactivity was observed in small clear vesicles and LDCVs at the extremities of the axons in the ME (white arrow).
Scale bar, 0.2 mm.
doi:10.1371/journal.pbio.1001952.g002
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whereas weight differences between males of these two genotypes
were only observed from PND 30 to PND 40 (Figure S5). We first
analyzed reproductive function. VO and first estrus occurred
significantly later in female nes-Cre;Dmxl2–/wt mice than in their
WT littermates (Figure 4B and 4C). The time from VO to first
estrus was significantly longer in nes-Cre;Dmxl2–/wt mice
(Figure 4D). Very few nes-Cre;Dmxl2–/wt females completed a
full estrous cycle over a 20-d period (Figure 4E), and they spent
less time in high estradiol levels (Figure 4F). In nes-Cre;Dmxl2–/wt
males, the anogenital distance (AGD) was significantly shorter
than that in their WT littermates, providing an external indicator
of low testosterone concentration (Figure 4G). Fertility was
assessed over a period of 3 mo. The female nes-Cre;Dmxl2–/wt
mice had very poor fertility, producing few, if any litters, and the
nes-Cre;Dmxl2–/wt males were subfertile (Table S3).
Phenotypic analyses were then pursued to characterize the
fertility problems observed in nes-Cre;Dmxl2–/wt mice. The
weights of testes and ovaries were low in nes-Cre;Dmxl2–/wt mice
(Figure 5A and 5B). A histological analysis of ovaries in female
nes-Cre;Dmxl2–/wt mice revealed the presence of normal numbers
of antral follicles associated with significantly fewer corpora lutea
than would normally be expected (Figure 5C). Estradiol
concentrations were normal in nes-Cre;Dmxl2–/wt females
(Figure 5D), whereas testosterone concentrations were signifi-
cantly lower in nes-Cre;Dmxl2–/wt males than in their WT
littermates (Figure 5E). LH concentrations were moderately, but
significantly, higher in nes-Cre;Dmxl2–/wt females than in WT
females (Figure 5F), whereas no difference in LH concentration
was observed between nes-Cre;Dmxl2–/wt and WT males
(Figure 5G).
The normal concentrations of LH observed despite the low
concentration of testosterone in male nes-Cre;Dmxl2–/wt mice was
indicative of a partial CHH due to a hypothalamic defect.
Consistent with this, nes-Cre;Dmxl2–/wt mice displayed normal
increases in LH concentration following the intraperitoneal
injection of GnRH (Figure 5H). The normal response to PMSG
injection of ovaries from nes-Cre;Dmxl2–/wt mice confirmed that
the very low rate of ovulation in nes-Cre;Dmxl2–/wt females was
related to a defect in the hypothalamo–pituitary control of the
gonadotropic axis (Figure 5I). The delayed puberty and infertility
observed in nes-Cre;Dmxl2–/wt mice was therefore due largely to a
hypothalamic defect.
Figure 3. Rbcn-3a is specifically expressed in gonadotropes in the pituitary. (A) Double-immunostaining for Rbcn-3a and LH or FSH in the
rat pituitary gland showed that Rbcn-3a was expressed in gonadotropes. Scale bars, 10 mm. (B) Double-immunostaining for Rab3GAP or Rab3GEP
revealed that these two proteins were present in both LH- and FSH-expressing cells. (C) Immunostaining with antibodies against Rbcn-3a, Rab3GAP,
or Rab3GEP and ACTH, TSH, and GH showed that Rbcn-3a, Rab3GAP, and Rab3GEP were not expressed in corticotropes, thyreotropes, and
somatotropes. Scale bars, 40 mm. Red staining, antibodies against Rbcn-3a, Rab3GAP, and Rab3GEP. Green staining, antibodies against pituitary
hormones.
doi:10.1371/journal.pbio.1001952.g003
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Figure 4. Female Nes-cre;Dmxl2–/wt mice displayed delayed puberty and were infertile. (A) Postnatal growth curve of female nes-
Cre;Dmxl2–/wt mice (black line, Dmxl2lox/wt; hatched gray line, nes-Cre;Dmxl2–/wt). (B and C) VO and first estrus occurred significantly later in female nes-
Cre;Dmxl2–/wt mice than in their WT littermates. (D) The interval from VO to first estrus was significantly longer in female nes-Cre;Dmxl2–/wt mice than
in WT mice, suggesting a defect in maturation of the HPG axis. (E) Very few complete estrous cycles were observed in female nes-Cre;Dmxl2–/wt mice.
(F) Female nes-Cre;Dmxl2–/wt spent less time in high estradiol concentration (M, miestrus; E, estrus; D, diestrus; P, proestrus). (G) A significant
difference in AGD was observed between male nes-Cre;Dmxl2–/wt mice and their WT littermates. Black line, Dmxl2lox/wt; hatched gray line, nes-
Cre;Dmxl2-/wt. White bars, Dmxl2lox/wt. Black bars, nes-Cre;Dmxl2–/wt. Numerical data used to generate graphs 4B, 4C, 4D, 4E, 4F, or graphs 4A, 4G may
be found in Table S5 and Table S6, respectively. Error bars are SEM. *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pbio.1001952.g004
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We characterized the hypothalamic defect in nes-Cre;Dmxl2–/wt
mice, by determining whether Rbcn-3a was produced in GnRH
neurons. Punctate Rbcn-3a staining was colocalized with GnRH in
the median and external layers of the ME (Figure 6A). Electron
microscopy confirmed that Rbcn-3a was present in GnRH neurons
(Figure 6B). We investigated whether the gonadotropin deficiency
observed in nes-Cre;Dmxl2–/wt mice was due to GnRH deficiency,
by quantifying GnRH mRNA levels in the hypothalamus of nes-
Cre;Dmxl2–/wt mice and comparing them with those of WT mice.
GnRH mRNA levels were significantly lower in nes-Cre;Dmxl2–/wt
Figure 5. nes-Cre;Dmxl2–/wt mice displayed a partial gonadotropin deficiency. (A and B) Weights of testes and ovaries were low in nes-
Cre;Dmxl2–/wt mice. (C) Histological analysis of ovaries showed a normal number of antral follicles but very few corpora lutea in female nes-Cre;Dmxl2–/wt
mice. (D) Estradiol concentrations were normal in female nes-Cre;Dmxl2–/wt mice. (E) Plasma testosterone concentration was low in male
nes-Cre;Dmxl2–/wt mice. (F) Plasma LH concentrations were moderately high in female nes-Cre;Dmxl2–/wt mice. (G) Despite their lower testosterone
concentrations, male nes-Cre;Dmxl2–/wt mice had normal plasma LH concentrations. (H) The GnRH-induced increase in LH concentration was normal in
nes-Cre;Dmxl2–/wt mice. (I) The administration of PMSG to young mice induced a normal increase in estradiol concentration in nes-Cre;Dmxl2–/wt mice,
similar to that observed in their WT littermates (asterisks indicate significant differences: * p,0.05, ** p,0.001; ***p,0.0001). Error bars: SEM. P, postnatal
day. White bars, Dmxl2lox/wt; black bars, nes-Cre;Dmxl2–/wt. Numerical data used to generate these graphs may be found in Table S5.
doi:10.1371/journal.pbio.1001952.g005
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Figure 6. Hypothalamic GnRHmRNA and GnRH-IR neuron levels are lower in the hypothalamus of nes-Cre;Dmxl2–/wt mice. (A) Rbcn-3a
is expressed in GnRH neurons in the median eminence. (B) Rbcn-3a is located in small clear vesicles and in LDCVs in GnRH neurons. White arrows
indicate Rbcn-3a DAB staining; white arrow heads indicate GnRH nanogold staining. (C) GnRH1 mRNA levels relative to RNA18S were lower in the
hypothalamus of nes-Cre;Dmxl2–/wt male mice than in WT mice. (D) The total number of GnRH-ir neurons in the brain was lower in nes-Cre;Dmxl2–/wt
male mice than in WT mice. (E) GnRH immunostaining in the OVLTs in Dmxl2lox/wt and nes-Cre;Dmxl2–/wt male mice. (F) An analysis of the rostral–
caudal distribution of GnRH-ir neurons in the hypothalamus revealed that nes-Cre;Dmxl2–/wt male mice had fewer GnRH-ir cell bodies in the OVLT (see
inset) than their WT littermates. * p,0.05, *** p,0.0001. White bars, Dmxl2lox/wt; black bars, nes-Cre;Dmxl2–/wt. Numerical data used to generate
graphs 6C, 6D, 6F, and 6F inset may be found in Table S5.
doi:10.1371/journal.pbio.1001952.g006
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mice than in WT mice (Figure 6C). This decrease was specific to
GnRH, as the amounts of mRNA for other hypothalamic-releasing
hormones were normal (Figure S6). The lower levels of GnRH
mRNA were associated with the presence of fewer GnRH-ir
neurons in the hypothalamus of nes-Cre;Dmxl2–/wt mice than in
WT littermates (Figure 6D). An analysis of the rostral–caudal
distribution of GnRH-ir neurons from the diagonal band of Broca
to the ME showed that there were significantly fewer GnRH-ir
neurons in the OVLT, this loss of neurons not being compensated
by an increase in the number of GnRH-immunoreactive (GnRH-ir)
neurons in the rostral or caudal parts of the hypothalamus
(Figure 6E and 6F). The poor fertility observed in nes-
Cre;Dmxl2–/wt mice was therefore associated with the presence of
fewer GnRH-ir neurons in the hypothalamus.
As patients with the c.5824_5838del of DMXL2 displayed
ataxia and mental disability, we investigated whether Dmxl2lox/wt
or nes-Cre;Dmxl2–/wt mice displayed neurological defects. We
analyzed the gait and exploratory behavior of these mice in an
open-field system [30]. No significant difference of the gait
between Dmxl2tm1a/wt mice and their WT littermates was
observed. However, nes-Cre;Dmxl2–/wt mice displayed significant-
ly higher levels of exploratory behavior than their WT littermates
(Figure S7).
Rbcn-3a Is Involved in the Regulated Secretion of Insulin
Severe abnormal glucoregulation, consistent with impaired
insulin secretion, was observed in the three affected brothers.
Rbcn-3a forms a complex with regulators of Rab3 GTPase, and
this complex is involved in the docking and priming of exocytosis
vesicles [31]. Insulin-secreting pancreatic islet b cells express many
proteins involved in the exocytosis of synaptic vesicles [32,33]. In
fact, Rbcn-3a was found to be present in pancreatic b cells
(Figure 7A). We therefore hypothesized that Rbcn-3a might be
involved in the regulated secretion of insulin. We tested this
hypothesis, by using siRNA to down-regulate Dmxl2 expression in
an insulin-secreting cell line (INS-1E). We observed a significant
decrease in Dmxl2 mRNA levels, to 25% those in nontarget (NT)
siRNA-transfected cells, 72 h after the transfection of INS-1E cells
with the Dmxl2 siRNA (Figure 7B). The knockdown of Dmxl2
expression with Dmxl2 siRNA resulted in significantly higher levels
of basal insulin secretion than for NT siRNA-transfected cells
(Figure 7C). By contrast to what was observed for NT siRNA-
transfected cells, the incubation of Dmxl2 siRNA-transfected cells
with 5 mM glucose did not increase insulin secretion, and only a
slight increase in insulin secretion was observed after incubation
with 20 mM glucose (Figure 7C). These in vitro experiments
demonstrate the involvement of Rbcn-3a in the control of
regulated insulin secretion.
Discussion
In this study, we found that a low level of DMXL2
haploinsufficiency caused a previously unknown complex pheno-
type in humans. The Warburg Micro and Martsolf syndromes
were considered the most relevant syndromes for comparison with
the phenotype reported here, as these syndromes are caused by
mutations affecting the catalytic (RAB3GAP1, p130) and non-
catalytic subunits (RAB3GAP2, p150) of RAB3GAP [18,19], two
components of the protein complex containing Rbcn-3a. Hypo-
gonadotropic hypogonadism, mental retardation, and demyelin-
ating peripheral neuropathy have been reported in patients with
RAB3GAP1 or RAB3GAP2 mutations [34], but the bilateral
cataracts, microphthalmia, and microcornea systematically found
in patients with the Warburg Micro and Martsolf syndromes were
not observed in this family. Furthermore, insulin-dependent
diabetes mellitus has not been reported in these syndromes. The
phenotype observed in this family was therefore different from
those of the Warburg Micro and Martsolf syndromes.
Mice expressing a conditional heterozygous null allele of Dmlx2
in neurons have very low fertility. This finding contrasts with the
observed phenotype of mice expressing a hypomorphic Dmxl2
allele and with findings for the family studied here, in which the
two c.5824_5838del-heterozygous parents were clearly fertile. We
suspect that the severity of the phenotype is highly associated to
the neuronal expression level of Dmxl2. The level of Rbcn-3a
expression in the neurons of nes-Cre;Dmxl2–/wt mice was found to
be 50% that in WT animals, whereas Dmxl2 expression in the
neurons of Dmxl2tm1a/wt mice was thought to be more than 50%
that observed in WT mice. DMXL2 mRNA levels were about
30% normal values in subjects homozygous for c.5824_5838del,
whereas they were about 60% normal values in subjects
heterozygous for this deletion (see Figure 1). Furthermore, we
were unable to obtain viable Dmxl2tm1a/tm1a mice. These mice died
during embryonic development, indicating a requirement of
Rbcn-3a for normal development in mice. This correlation
between DMXL2 expression level and the severity of the
neurological and neuroendocrinological phenotypes in both mice
and humans is consistent with a probable synaptic function for
Rbcn-3a. The phenotypic discrepancy between mice and humans
may also result from the interactions of different partners with
Rbcn-3a. It may also reflect the fact that the threshold of the
neuronal expression level of Dmxl2 causing a phenotype may be
species-specific.
An investigation of gonadotropic axis function in adult nes-
Cre;Dmxl2–/wt mice showed that the partial gonadotropic
deficiency was associated with the presence of a smaller total
number of GnRH-ir neurons. Multiple mechanisms may be
involved, such as a defect of GnRH neuron differentiation in the
OP, migratory failure, or a defect in the maturation and postnatal
survival of these GnRH neurons. The latter follow a unique
migratory route, emerging in the OP at E10.5 and then entering
the forebrain at E.13.5, to migrate along olfactory/vomeronasal
nerve axons before turning toward the hypothalamus, where they
are dispersed in the preoptic area (POA) and extend their axons by
E16.5 [35]. Many of the factors controlling GnRH neuron
migration also influence or control the development of the olfactory
system [35]. Olfactory bulbs developed normally in nes-
Cre;Dmxl2–/wt mice, demonstrating that the smaller number of
GnRH neurons in the POA region of nes-Cre;Dmxl2–/wt adult mice
was not associated with a defect of olfactory/vomeronasal nerve
axon development. This result is consistent with the absence of
anosmia and olfactory bulb agenesis in the patients with DMXL2
mutations. Furthermore, the analysis in adult mice showed that the
migration of GnRH neurons was not halted in the forebrain.
Preliminary data suggested that adult nes-Cre;Dmxl2–/wt mice had
a GnRH neuron morphology in the rostral POA that was more
complex than the normal unipolar/bipolar morphology displayed
by their WT littermates. This region contains the GnRH neuron
population of the greatest importance for the onset of puberty and
fertility. This complex morphology may indicate that GnRH
neurons did not progress toward a mature form. This led us to
suspect that there might be a defect in the postnatal development of
GnRH neurons in nes-Cre;Dmxl2–/wt mice. It is interesting to note
that Rbcn-3a was recently shown to be required for neural crest cell
migration and cell fate determination by controlling the Wnt
signaling pathway [36].
The observation that siRNA-induced down-regulation of Dmxl2
expression led to an increase in spontaneous insulin release and a
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disruption of glucose-induced insulin release in INS-1E cells is
consistent with a role for Rbcn-3a in controlling the secretion of
insulin in vivo. The episodes of hypoglycemia during childhood in
the human patients, associated with the lack of a blockade of
insulin release, may be accounted by a decrease in the inhibition of
basal insulin release by Rbcn-3a. By contrast, the occurrence of
insulin-dependent diabetes mellitus during adolescence in the
affected patients indicates an inability of the pancreas to respond
to the increase in insulin requirement at puberty [37]. This role of
Rbcn-3a in controlling insulin release is consistent with the recent
report of an association between the MAP kinase-activating death
domain (MADD) protein locus, also known as RAB3GEP, with
fasting glycemia and plasma proinsulin concentrations [38,39].
Rab27a is a monomeric GTPase protein very similar to Rab3.
Rab27a mediates glucose-specific signals for the exocytosis of
insulin vesicles in the pancreas [40]. Further investigations are
required to confirm the role of Rbcn-3a in insulin release in vivo
and to determine whether this protein may also act via the Rab27
pathway.
As the cellular machinery controlling vesicle exocytosis is similar
in pancreatic b cells and neurons [32,33], we can assume that
Rbcn-3a is involved in neurosecretion. Rbcn-3a may exert its
neurosecretory functions by controlling the ‘‘on/off’’ activity of
Rab3a [41,42]. However, the severity of the phenotypes observed
in this family and in patients with RAB3GAP1 and RAB3GAP2
mutations [18,19] contrast with the mild deficiency of Ca2+-
triggered neurotransmitter release caused by Rab3a deletion [43].
Other vesicle exocytosis steps may thus be impaired when Dmxl2
expression levels are low in neurons [44–46]. The neurotransmit-
ter glutamate is involved in the regulation of GnRH secretion [3].
Glutamate release is controlled by the amount of active Rab3a
[42], suggesting that glutamate-induced GnRH neuron activation
may be impaired in nes-Cre;Dmxl2–/wt mice. This possible
dysfunction of the glutamatergic input in GnRH neurons may
be responsible for the loss of GnRH neurons in nes-Cre;Dmxl2–/wt
mice. Defective V-ATPase–mediated acidification of exocytosis
vesicles may also contribute to the phenotype [47]. The expression
of Rbcn-3a, Rab3-GEP, and Rab3-GAP in gonadotropes only
suggests that these three proteins may specifically regulate the
secretion of LH and FSH. A dual defect in hypothalamic
neuropeptide and gonadotropin secretion may thus contribute to
the gonadotropic axis deficiency observed in the studied family.
We found in this study that low levels of Dmxl2 expression
caused a complex neurological and endocrine phenotype in
humans. Low levels of Dmxl2 expression in neuronal cells of mice
lead to a partial gonadotropic axis deficiency, resulting in a very
low fertility, due to a loss of GnRH neurons in the hypothalamus.
Our results strongly suggest that the loss of these neurons is due to
a dysfunction of peptide/neurotransmitter release by GnRH
neurons itself or the neurons innervating GnRH neurons. This
Figure 7. Dmxl2 knockdown in INS-1E cells decreases glucose-induced insulin release. (A) Rbcn-3a is expressed in insulin-secreting cells in
the islets of Langerhans in the mouse pancreas. (B) Seventy-two hours after the transfection of INS-1E cells with Dmxl2-siRNA, Dmxl2mRNA levels had
decreased by 75% (error bars: SEM; from three independent experiments). (C) Seventy-two hours after siRNA transfection, the release of insulin was
evaluated by quantifying insulin concentrations in cell supernatants. In the absence of glucose, insulin concentrations in Dmxl2-siRNA–transfected
cells were double those in cells transfected with NT siRNA (NT-siRNA). In the presence of various concentrations of glucose (5 and 20 mM), Dmxl2-
siRNA–transfected cells displayed only a small increase in insulin release, at a glucose concentration of 20 mM only, whereas a 2- to 3-fold increase
was observed with NT siRNA-transfected cells. Error bars: SEM from one representative experiment performed twice, in hextuplicate. * p,0.05, ** p,
0.001, *** p,0.0001. Numerical data used to generate graphs 7B and 7C may be found in Table S5.
doi:10.1371/journal.pbio.1001952.g007
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association of a low level of expression of a vesicular protein and
the loss of GnRH neurons constitutes a new mechanism of GnRH
deficiency. This study opens up new possibilities for characterizing
the pathogenic mechanisms of GnRH deficiency and the neuronal
control of the GnRH network.
Materials and Methods
This study was approved by the institutional review boards of
Robert Debre´ Hospital and Paris Diderot University. All
participants provided informed written consent for genetic
analyses. Animals were deeply anesthetized by pentobarbital
injections. The number of the ethical approval was 2012-15-676-
0099. It was delivered by the IFR Claude Bernard.
Genome Mapping and Characterization of the Genetic
Abnormality
DNA was extracted from peripheral blood lymphocytes and
genotyped with an Affymetrix 250k Nsp array, according to the
manufacturer’s instructions. Linkage analysis was performed by
classical techniques [48,49]. Call rates were .98%, and multi-
point LOD scores were calculated with Allegro-v1.2c [49], after
the random selection of one informative SNP every 500 kb,
following data quality control with Alohomora-v0.33 software
[48]. A fully penetrant recessive transmission model was assumed,
with a disease allele frequency of 0.00001. Two genomic regions
were found to have LOD scores of 2.5, corresponding to the
maximum possible LOD score for this family. High-throughput
sequencing of the two candidate regions was performed at the
‘‘Centre National de Ge´notypage’’ in Evry, France. Sanger
sequencing of DMXL2 exons was performed for all family
members (Figure S1) and for 10 additional patients. Primer
sequences are available upon request.
Expression Analysis by Quantitative RT-PCR
Total RNA was extracted from blood lymphocytes from the
patients, with a QiaAMP RNA Blood Mini Kit (Qiagen),
according to the manufacturer’s instructions. Total RNA was
extracted from mouse tissues with Trizol (Life Technologies). The
first-strand cDNA was synthesized with the Superscript II first-
strand synthesis kit (Invitrogen), with random primers or oligodT.
Human DMXL2 and 18S mRNA levels in the patients’
lymphocytes were quantified in specific DMXL2 and RNA 18S
Taqman gene expression assays on a 7300 Real-Time PCR
System (Applied Biosystems). Reverse transcription–quantitative
PCR (RT-qPCR) analysis of gene expression in INS-1E cells or in
mouse tissues was performed with the SyberGreen MasterMix
(BioRad, Hercules, CA), in a CFX 384 Real-Time PCR
Detection System (BioRad). The primer sequences used are
available upon request. Gene expression levels are expressed
relative to those of RNA 18S or GAPDH, as follows:
10062(e2DCtGene/e2DCtHousekeeping Gene).
In Situ Hybridization (ISH)
We analyzed Dmxl2 expression in the brain by performing ISH
on C57Bl6 mouse brain, with a probe generated from a DNA
template obtained by PCR. A digoxigenin UTP-labeled Dmxl2
probe was synthesized by generating a DNA template by PCR,
with the Expand High-Fidelity PCR system (Roche Diagnostics)
and a pair of primers binding between nucleotides 222 and 1068
of the mouse Dmxl2 cDNA sequence (NCBI Reference Sequence
NM_172771.2) and carrying the SP6 and T7 promoter sequences.
The PCR product was used as the DNA template for the
transcription of digoxigenin-UTP probes with an SP6 and T7 DIG
RNA labeling kit (Roche Diagnostics).
ISH was carried out on 200-mm mouse brain sections. Mouse
brains were embedded in a 5% agarose/BSA preparation and
sectioned with a vibratome (Leica VT 1000 S). Sections were
dehydrated by passage through a graded series of ethanol solutions
and were stored frozen at 220uC. Sections were rehydrated and
ISH was carried out as previously described [50]. Sections were
mounted on glass slides, in 80% glycerol in PBS, and images were
captured under a microscope (Leica DM IRB), at a magnification
of 1.66. Half-brain images were reconstituted from several images
of the same section, taken at the same time and under the same
conditions.
Immunohistochemistry (IHC)
For the analysis of Rbcn-3a expression in the rodent pituitary
and brain, tissues were prepared from C57BL6 mice and/or WKY
rats, as previously described [51]. The rodents were deeply
anesthetized by pentobarbital injections and perfused transcar-
dially with 4% paraformaldehyde in 0.1 M phosphate-buffered
saline (PBS), pH 7.4. Brains were removed, cryoprotected in 30%
sucrose, frozen in liquid isopentane at 245uC, and stored at
280uC until sectioning. We cut 30-mm coronal sections on a
cryostat, and the free-floating sections were processed for IHC.
For immunofluorescence, sections were incubated with 5% normal
donkey serum (NDS) and 0.4% Triton X-100 in PBS (PBS-T) for
45 min. Sections were then incubated with primary antibodies in
1% donkey serum in PBS-T, for 48 h at 4uC (Table S4). Sections
were rinsed several times with PBS and then incubated with a
fluorescent secondary antibody for 1 h at room temperature (RT).
They were then washed three more times in PBS, counterstained
with TO-PRO-3 (1/500, Invitrogen), rinsed in PBS, mounted on
Superfrost Plus slides (Microm Microtech) in Fluoromount
(Southern Biotech), and covered with a coverslip.
For immunoperoxidase staining, the same procedure was
followed, except that the sections were incubated with a
biotinylated secondary antibody for 90 min at RT. The sections
were incubated with 1% H2O2 in PBS for 10 min, rinsed in PBS-
T, and labeling was detected with the Vectastain ABC kit (Vector
Laboratories, Burlingame). Sections were then mounted in Pertex
resin.
The analysis of the GnRH neuron distribution was processed
with the SW-1 antibody [52] at a dilution of 1:3,000 in PBST
(0.4%), for 48 h at 4uC, in the presence of 2% NDS and then as
described above. The total number of GnRH-IR neurons was
quantified in serial 40-mm coronal sections from the anterior
preoptic region to the posterior hypothalamus in adult mice (PND
60), as previously described [53]. All slides were coded and scored
blind. A neuron was scored as GnRH-IR only if it had a clearly
stained cell body. We analyzed the distribution of GnRH-ir
neurons further, designating the start of the OVLT as section 0.
We numbered the 20 sections on either side of section 0 in the
OVLT. This analysis did not include the regions in the immediate
vicinity of the olfactory bulbs, but it did encompass most of the
GnRH neuronal system of the mouse brain.
For double-labeling fluorescent IHC, sections were first rinsed
in PBS and preincubated for 30 min in 5% NDS in PBS
containing 0.3% Triton X-100. Sections were coincubated
overnight at RT in ADD AbIs diluted in PBS containing 1%
NDS and 0.3% Triton X-100. Sections were then rinsed in PBS
and incubated for 1 h in GIVE THE AbIIs Alexa Fluor 488-
conjugated donkey anti-rabbit IgG (1:200; Molecular Probes) and
Cy3-conjugated donkey anti-mouse IgG (1:300; Jackson Immu-
noResearch) diluted in PBS containing 3% NDS and 0.3% Triton
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X-100. Sections were then rinsed in PBS, counterstained with
DAPI (1/4,000), mounted on glass slides, and coverslipped with
Fluoromount-G solution (Southern Biotech) for confocal micro-
scopic examination.
Immunofluorescent sections were analyzed using a Leica TCS
SP8 confocal scanning system (Leica Microsystems) equipped with
488-nm Ar, 561-nm DPSS, and 633-nm HeNe lasers. Eight bit
digital images were collected from a single optical plane using a
636HC PL APO CS2 oil-immersion Leica objective (numerical
aperture, 1.40) or a 406HC PL APO CS2 oil-immersion Leica
objective (numerical aperture, 1.30). For each optical section,
double/triple-labelled images were acquired in sequential mode to
avoid potential contamination by linkage-specific fluorescence
emission cross-talk.
Electron Microscopy
C57BL6 WT adult mice (PND 60) were anesthetized with
0.2 cm3 of 10% chloral hydrate and intracardially perfused with
100 ml of 4% PFA, 0.1% glutaraldehyde in 0.1 M phosphate
buffer (pH 7.4) on ice. Brains were postfixed by overnight
incubation in 4% PFA at 4uC. The following day, the
hypothalamus was dissected and cut into 200-mm sections in ice-
cold PBS. These sections were then processed for pre-embedding
IHC with an antibody against rabconnectin-3 [54]. For this
purpose, sections were immersed for 20 min in 50 mM ammoni-
um chloride in PBS, rinsed, and incubated overnight at 4uC with
rabbit anti–rabconnectin-3a antibody (1:500) in PBS containing
0.1% gelatin (PBSg). Antibody binding was detected by incubating
sections with a goat anti-rabbit biotinylated antibody (1:200) in
PBS-gelatin for 4 h at RT and then with an avidin–peroxidase
complex (1:200) for 3 h (Elite Vectastain kit, Vector Laboratories).
Finally, sections were incubated with 0.6% diaminobenzidine in
Tris-buffered saline and then with Sigma Fast DAB. After staining,
the region of interest, the ME, was further dissected and
embedded in epoxy resin, for the cutting of semithin sections
(0.5 mm), which were stained for visualization of the ME. Ultrathin
sections (70 nm) of the ME were then cut and collected on 400-
mesh formvar-coated nickel grids and examined with a Jeol JEM-
100CXII electron microscope.
For dual labeling with Rbcn-3a and GnRH antibodies, the ME
was carefully dissected out, rinsed in PBS, and incubated in 20%
glycerol/20% sucrose in PBS for 3 h. ME sections were then
placed carefully in liquid nitrogen for three freeze cycles, rinsed in
NH4Cl, and washed in PBSg. ME sections were incubated
overnight in mouse anti-GnRH antibody, at a dilution of 1:200 in
PBSg, at 4uC. The sections were then washed in PBSg, incubated
with goat anti-mouse secondary antibody conjugated to gold
particles (Aurion, Biovalley), at a dilution of 1:100, for 4 h at RT
(nanogold). Sections were washed in PBS. The nanogold particle
signal was amplified with a BBI Amplification silver kit, for 7 min
at RT, followed by gold toning. The sections were rinsed in PBS
and incubated overnight at 4uC with rabbit anti–Rbcn-3a, at a
dilution of 1:500 in PBSg. Rbcn-3a staining was detected by
incubating the sections with donkey anti-rabbit biotinylated
antibody at a dilution of 1:200 in PBSg at RT, rinsing in PBS,
and then incubating with an avidin–biotin complex at a dilution of
1:200, with the detection of DAB staining after postfixation (1%
glutaraldehyde) with SigmaFast tablets (Sigma Aldrich). The DAB
reaction was stopped with Tris-HCL, and the sections were
washed in PBS. Sections were incubated with osmium tetraoxide
for 1 h at 4uC and dehydrated for embedding in epoxy resin, flat
embedding, and polymerization. Sections embedded in epoxy
resin blocks were subsequently cut into semithin (0.5–2 mm) and
ultrathin (70 nm) sections and analyzed by electron microscopy.
In Vitro Analysis of Insulin Secretion
The role of Rbcn-3a in regulated insulin secretion was
analyzed in the rat insulinoma-derived INS-1E cell line by
knocking down Dmxl2 expression with siRNAs directed against
Dmxl2. Glucose-induced insulin release into the supernatant of
Dmxl2 siRNA-transfected cells was then compared with that
from NT siRNA-transfected cells. The rat insulinoma-derived
INS-1E cell line was kindly provided by Prof. Pierre Maechler
and Prof. Claes Wollheim [55]. Cells were cultured in RPMI-
1640 medium supplemented with 5% fetal calf serum. Twenty-
four hours before transfection, cells were used to seed 96-well
culture plates (BD Biosciences), in complete culture medium.
They were then transfected with 100 nM siGENOME Smart
Pool Rat LOC315676 siRNA against rat Dmxl2 (Thermo
Scientific) or 100 nM control siGENOME NT siRNA #1
(Thermo Scientific), in the presence of Dharmafect 2 transfec-
tion reagent (Thermo Scientific). The cells were incubated for
72 h, washed once in PBS, and used for total RNA extraction
with Trizol reagent. Cells transfected with either Dmxl2 or NT
siRNA were incubated for 3 h with Krebs-Ringer bicarbonate
buffer supplemented with 0.35% BSA (KRBH-BSA; Sigma
Aldrich). They were then incubated in the same buffer with 0, 5,
or 20 mM D(+) glucose monohydrate (Sigma Aldrich) for
90 min at 37uC, and insulin secretion was evaluated with the
sensitive-range protocol of the HTRF insulin assay (Cisbio
Bioassays).
Generation of Dmxl2 Hypomorphic and Nestin-cre/Dmxl2
Mice
The gene targeting vector used to decrease the expression of
Dmxl2 in all cells included an additional acceptor splice site in
intron 6, LacZ under the control of the endogenous Dmxl2
promoter, a neomycin resistance (neoR) cassette under the control
of the actin promoter, and loxP sites flanking the critical Dmxl2
exon 7 (Figure S2). The vector (Dmxl2tm1a(EUCOMM)Wtsi) was
injected into JM8-F6 embryonic stem cells at the European
Conditional Mouse Mutagenesis Program (EUCOMM). These
cells were then injected into C57Bl/6N blastocysts at the
Transgenic Animal Service (SEAT; Villejuif, France) to create
chimeric mice, which were crossed to create Dmxl2 hypomorphic
(Dmxl2tm1a/wt) mice. This mouse line was transferred to the
INSERM U1141 animal facility, where the animals were
housed under a 12 h light/12 h dark cycle and fed ad libitum.
Dmxl2tm1a/wt mice were intercrossed to obtain Dmxl2wt/wt and
Dmxl2tm1a/wt mice. However, we were unable to obtain any
Dmxl2tm1a/tm1a mice due to embryonic lethality.
A conditional KO of Dmxl2 was obtained by crossing
Dmxl2tm1a/wt mice with FLIP (FLP) recombinase-expressing mice,
to remove the b-galactosidase cassette and the neomycin resistance
gene and to create Dmxl2lox/lox mice, which were then crossed with
nes-Cre mice to obtain mice with a conditional deletion of Dmxl2
in neurons and glial cells (nes-Cre;Dmxl2–/wt).
Genotyping of Mice
Genomic DNA was obtained on postnatal day (PND) 21 (tail
biopsy) and PND 60 (brain tissue), and each animal was genotyped
by PCR. For detection of the Dmxl2 GT cassette, two primers
flanking the 59 and 39 regions of the GT cassette (Dmxl2 59-arm
and Dmxl2-39arm) were used, together with another primer
designed to bind within the 59-arm of the GT cassette (Dmxl2
LAR3) (www.knockoutmouse.org/about/eucomm). A separate
PCR analysis of genomic DNA was used to investigate the
presence of the Nestin-Cre allele.
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Phenotyping of Dmxl2 KO Mice
The reproductive phenotype was assessed at 16:00 hours, at 5-d
intervals, in male mice and for 20 consecutive days after weaning
(PND 21) in females. In males, AGD was recorded from weaning
(PND 21) to PND 60 (AGD). In females, three parameters were
assessed: (1) age at VO, (2) age at first estrus, and (3) the interval
between VO and first estrus. Estrous cyclicity was monitored daily
after VO, at 16:00 hours, for 20 consecutive days, by vaginal
lavage.
GnRH Injections to Test Gonadotrope Responsiveness
Male mice underwent subcutaneous injections of 100, 200, 300,
and 400 ng/kg GnRH in an initial trial experiment, to determine
an appropriate submaximal dose for the LH response. A dose of
300 ng/kg was chosen as the submaximal dose for use in
subsequent experiments. Five male mice of each genotype received
100 ml i.p. injections of 300 ng/kg GnRH (Sigma Aldrich) or
vehicle (0.9% saline). Ten minutes after injection, mice were
anesthetized rapidly by isoflurane inhalation and decapitated for
trunk blood collection. Plasma was isolated at 4uC, after the
centrifugation of blood samples at 3,0006g for 10 min. Plasma
samples were then stored at 220uC until use.
PMSG Test of Ovarian Responsiveness
Five young (PND21-PND23) female mice of each genotype
underwent i.p. injections of 0.4 IU/g PMSG (Sigma Aldrich) or
vehicle (0.9% saline). They were anesthetized with isoflurane
vapor 48 h later and decapitated for trunk blood isolation. Plasma
was isolated at 4uC, by centrifugation at 3,0006g for 10 min.
Hormone Assays
Trunk blood from adult PND60 mice was collected into
heparin, after decapitation at 16:00. The blood was immediately
placed on ice and was then centrifuged at 4uC and 3,0006g for
10 min. Plasma was subsequently harvested and stored at 220uC
until analysis. Plasma luteinizing hormone concentrations were
assessed by a radioimmunoassay (RIA) [56]. Plasma estradiol
concentrations were determined with an estradiol enzyme
immunoassay (EIA) kit (Caymen Chemicals, 582251). The 80%
B/B0 detection limit for this kit is approximately 19 pg/ml, with a
sensitivity of 129 pg/ml. Testosterone concentrations in humans
and mice were assessed by RIA.
Statistical Analysis
Samples were analyzed by one-way ANOVA, with Bonferroni
correction if there were more than two groups, and two-tailed
Student’s t tests were used for pairwise comparisons (WT versus
KO). Statistical analyses were carried out with Prism software
(GraphPad, La Jolla, CA). Differences were considered significant
if p,0.05.
Supporting Information
Figure S1 Sanger sequencing analysis of exon 24 of DMXL2 in
the family. Extracts of Sanger sequencing chromatograms for exon
24 of DMXL2 for one affected patient (#123), one heterozygous
parent (#121), and one WT sister (#127). Primer sequences are
available upon request. The in-frame deleted region in exon 24 is
underlined in the chromatogram of patient #127. DMXL2 was
identified as an interesting candidate gene by the next-generation
sequencing of two candidate regions delineated by genome
mapping. All exons of these two regions were captured from the
proband DNA and his mother DNA and sequenced with the
454 sequencing system. We found 3,295 single-nucleotide
polymorphisms in the two DNA samples, 2,015 of which were
common to the proband and his mother. Among these 2,015
SNPs, 1,612 had previously been reported in HapMap and
dbSNP. Of the 403 unknown SNPs in these two databases, 91
were present in mRNAs, but only 20 were present in coding
sequences. Six of these variants were considered to be of interest.
These variants were located in ZNF770, MTMR15, TMCO5A,
and DMXL2 (Table S7). ZNF770, MTMR15, and TMCO5A
were rejected, as the variants concerned were reported in the 1000
Genomes database (browser.1000genomes.org) and/or the sub-
stituent amino acids were present in the proteins of other species.
Applying the criteria described above, none of the DNA variants
found on chromosome 13 were considered valid candidates. This
left only one potentially interesting variant in DMXL2 on
chromosome 15. This DNA variant was an in-frame deletion of
15 nucleotides (c.5824_5838del) in exon 24, leading to a deletion
of five amino-acid residues from the protein (p.1942_1946del). A
similar but not identical deletion (c.5827-5842del16) has recently
been reported in the exome variant server (http://evs.gs.
washington.edu), with a frequency of 3/10,000 but without the
identification of a homozygous carrier. The sequence shown is the
coding sequence. DMXL2 is encoded by the minus strand. M,
mutated allele; wt, WT allele.
(EPS)
Figure S2 Analysis of Rbcn-3a expression in the hypothalamus
and cerebellum. IHC was performed on floating sections as
described in ‘‘Materials and Methods.’’ (A) Rbcn-3a staining was
observed in the granular layer (GL) as well as molecular layer (ML)
in the cerebellum. Note that purkinje cells do not express Rbcn-3a
(white arrow heads). (B) Rbcn-3a immunostaining was observed in
the SCN as well as along the third ventricle (V3) in the
periventricular nucleus (Pe). (C and D) A positive staining was
also observed in the SFO and the subcomissural organ (CMO).
Black arrow heads indicate positive staining.
(TIF)
Figure S3 The EUCOMM Dmxl2 gene trap allele with
conditional potential and the Dmxl2 allele after the action of
Cre recombinase. (A) The Dmxl2 gene trap allele (tm1a allele)
contains an IRES:LacZ trapping cassette with an acceptor splice
site (En2 SA) and a floxed neoR cassette. LoxP sites flank the
critical exon 7 and the neoR cassette. FRT sites flank the
IRES:LacZ and neoR cassettes (adapted from www.
knockoutmouse.org/about/eucomm). The IRES:LacZ trapping
cassette and the floxed neoR cassette have been deleted by the
FLIP recombinase to generate Dmxl2lox/lox mice. The critical exon
7 was then deleted by the Nestin cre-recombinase to generate both
Dmxl2lox/wt (WT) and nes-Cre;Dmxl2–/wt. Dashed lines indicate
possible RNA splice isoforms. Single-headed orange or blue
arrows represent the positions of the PCR primers used to
genotype mice. (B) Relative expression of Dmxl2 in the
hypothalamus of nes-Cre;Dmxl2–/wt mice; comparison with results
for WT littermates. Total RNA was extracted from the dissected
hypothalamus of nes-Cre;Dmxl2–/wt and Dmxl2lox/wt mice and
reverse-transcribed with random primers. The Dmxl2 cDNA was
then quantified by qPCR, as described in ‘‘Materials and
Methods.’’ *** p,0. 001. White bar, Dmxl2lox/wt mice; black
bar, nes-Cre;Dmxl2–/wt mice. Numerical data used to generate
graph S3B may be found in Table S5.
(EPS)
Figure S4 Analysis of the age at VO and the time between VO
and the age at the first estrus in Dmxl2tm1a/wt mice. (A) A tendency
toward an older age at VO. (B) A higher time between VO and the
age at the first estrus was observed in Dmxl2tm1a/wt mice (gray bars)
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as compared to WT littermates (white bars). Numerical data used
to generate these two graphs may be found in Table S5.
(EPS)
Figure S5 Growth curve of nes-Cre;Dmxl2–/wt male mice as
compared to their WT littermates Dmxl2lox/wt mice. Numerical
data used to generate this graph may be found in Table S6.
(EPS)
Figure S6 Quantification of corticotropin-releasing hormone
(CRH) and thyrotropin-releasing hormone (TRH) mRNA levels in
the hypothalamus of nes-Cre;Dmxl2–/wt mice. Hypothalami of nes-
Cre;Dmxl2–/wt and Dmxl2lox/wt mice were dissected, and total RNA
was extracted as described in ‘‘Materials and Methods.’’ Levels of
CRH and TRH mRNA were assessed by quantitative RT-qPCR.
Primer sequences are available on request. CRH, corticotropin-
releasing hormone; TRH, thyrotropin-releasing hormone. White
bars, Dmxl2lox/wt mice; black bars, nes-Cre;Dmxl2–/wt mice.
Numerical data used to generate these two graphs may be found
in Table S5.
(EPS)
Figure S7 Investigation of gait and exploratory behavior in nes-
Cre;Dmxl2–/wt mice. The Neogait Openfield system was used for
automatic measurement of the gait and exploratory behavior of
Dmxl2lox/wt and nes-Cre;Dmxl2–/wt mice. Gait was assessed by
measuring two variables: distance from the starting point to the
end point and the distance covered (number of blocks occupied).
No significant differences in gait were found between any of the
genotypes tested. However, there was a significant difference in the
number of blocks occupied, indicating higher levels of exploratory
behavior in nes-Cre;Dmxl2–/wt mice than in their WT littermates.
This difference disappeared in the second trial, suggesting a
possible effect of fatigue, as the two trials were separated by an
interval of only about 20 min. White and black bars represent the
means of blocks occupied in trials 1 and 2 by nes-Cre;Dmxl2–/wt
mice or their WT litter mates, respectively (see numerical data in
Table S5).
(EPS)
Table S1 Body weight in nes-cre;Dmxl2tm1a/wt mice. The body
weights of male Dmxl2tm1a/wt and Dmxl2wt/wt mice were not
significantly different. PND, postnatal day.
(DOC)
Table S2 Fertility analysis in nes-Cre;Dmxl2tm1a/wt mice. Total
number of litters, pups, sex of pups, genotype of pups, and mean
litter size for all mice analyzed for this study over a 6-mo period.
(DOC)
Table S3 Fertility tests in nesCre;Dmxl2–/wt mice.
(DOC)
Table S4 Antibodies used for IHC.
(DOC)
Table S5 Numerical data used to generate graphs. These data
were those used to generate graphs and to perform statistical
analyses. In Figures 4B, 4C, 4D, 4E, S4A, and S4B, units are
postnatal days. In Figure 4F, units are the time spent in each
estradiol concentration (percentage) in one ovarian cycle. In
Figure 5A and 5B, units are the means of the weight of both
gonads (milligrams). In Figure 5C, units are the mean number of
follicles observed in ovaries. In Figure 5D and 5I, units are
estradiol concentrations in pg/ml. In Figure 5E, units are
testosterone concentrations in ng/ml. In Figure 5F–H, units are
LH concentrations in ng/ml. In Figure 1D, units are DMXL2
mRNA levels relative to RNA 18S in blood lymphocytes of
patients and controls (1006). In Figures 6C, S3B, S6A, and
S6B, units are mRNA relative values to the mean measured in
Dmxl2lox/wt mice. In Figure 7B, units are Dmxl2 mRNA levels
relative to RNA18S levels (1006). In Figure 7C, units are the
insulin concentrations in ng/ml. In Figure 6D, 6F, and 6F inset,
units are the number of GnRH-IR neurons. In qPCR analysis,
Dup1 and Dup2 indicate duplicate 1 and duplicate 2, respectively.
(XLSX)
Table S6 Numerical data used to draw graphs of the postnatal
growth in both sexes and the AGDs in males. In Figures 4A and
S5, data are the weights of mice in grams. In Figure 4G, data are
the distance in millimeters.
(XLSX)
Table S7 List of six selected DNA variants in the two candidates
regions. The selection criteria were those defined in the legend of
Figure S1. The genome reference is hg18.
(XLSX)
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